Quest Diagnostics Incorporated
DGX
Rang in Aktien
#929
Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus,... Quest Diagnostics Incorporated, founded in 1967 and headquartered in Secaucus, New Jersey, is a premier provider of diagnostic testing, information, and related services, serving clients both domestically and internationally. Its core business involves the development and provision of diverse diagnostic information services, such as routine, advanced clinical, and anatomic pathology testing. While primarily operating under the Quest Diagnostics brand, it also leverages specialized identities like AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum to reach a broad spectrum of clients. Its extensive client base includes patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and other direct healthcare entities. Delivery of these services is facilitated through a robust network comprising laboratories, patient service centers, in-office phlebotomists, call centers, and mobile health professionals including paramedics and nurses. Additionally, the company provides risk assessment services for the life insurance industry and offers comprehensive information technology solutions to healthcare organizations and clinicians.
Aktienkurs
$236.69
Marktkapitalisierung
$26.12B
Veränderung (1 Tag)
0.80%
Veränderung (1 Jahr)
24.31%
Land
US
Handel Quest Diagnostics Incorporated (DGX)
Kategorie
Healthcare
Anzahl der ausstehenden Aktien von Quest Diagnostics Incorporated (DGX)
Anzahl der ausstehenden Aktien zum June 2026: 110.00M
Laut den neuesten Finanzberichten und dem Aktienkurs von Quest Diagnostics Incorporated beträgt die aktuelle Anzahl der ausstehenden Aktien 110.00M. Am Ende von December 2024 hatte das Unternehmen 111.00M ausstehende Aktien. Die Anzahl der ausstehenden Aktien wird normalerweise durch Aktiensplits und Aktienrückkäufe beeinflusst.
Verlauf der ausstehenden Aktien von Quest Diagnostics Incorporated (DGX) von 2000 bis 2026
Ausstehende Aktien am Ende jedes Jahres
| Jahr | Ausstehende Aktien | ändert |
|---|---|---|
| 2026 (TTM) | 110.00M | -0.90% |
| 2025 | 111.00M | 0.00% |
| 2024 | 111.00M | -0.89% |
| 2023 | 112.00M | -3.45% |
| 2022 | 116.00M | -7.20% |
| 2021 | 125.00M | -6.72% |
| 2020 | 134.00M | 0.00% |
| 2019 | 134.00M | -1.47% |
| 2018 | 136.00M | -0.73% |
| 2017 | 137.00M | -2.14% |
| 2016 | 140.00M | -2.78% |
| 2015 | 144.00M | -0.69% |
| 2014 | 145.00M | -4.61% |
| 2013 | 152.00M | -4.16% |
| 2012 | 158.60M | -0.06% |
| 2011 | 158.70M | -9.68% |
| 2010 | 175.70M | -5.49% |
| 2009 | 185.90M | -4.32% |
| 2008 | 194.30M | 0.55% |
| 2007 | 193.24M | -1.90% |
| 2006 | 196.99M | -2.40% |
| 2005 | 201.83M | -0.94% |
| 2004 | 203.75M | -1.56% |
| 2003 | 206.97M | 7.29% |
| 2002 | 192.91M | 3.40% |
| 2001 | 186.56M | 4.20% |
| 2000 | 179.04M | 0.00% |
Ausstehende Aktien bei ähnlichen Unternehmen oder Wettbewerbern
| Unternehmen | Ausstehende Aktien | Unterschied | Land |
|---|---|---|---|
| 371.00M | 237.27% |
US
|
|
| 705.30M | 541.18% |
US
|
|
| 143.28M | 30.25% |
US
|
|
| - | - |
CN
|
|
| 282.00M | 156.36% |
US
|
